IGF2 and neoplasm: Remarkably, by just probing tumor mutation landscape, we cannot assess IGF2 downregulation, but, at this juncture, sc-RNA seq of CTC proved to be an outstanding tool in detecting non-mutated genomic aberrations like overexpression of IGF2 [41].